Valeomed Egészségközpont - dr. Sátori Mária neurológus főorvos elsősorban fejfájás, szédülés, demencia, stroke, sclerosis multiplex betegségek, gerincpanaszok kezelésével foglalkozik. Foglalj időpontot honlapunkon vagy hívj bennünket a 06 30 / 46 46 583
![Harrow + Wunderink + Open Dialogue = An Evidence-based Mandate for A New Standard of Care - Mad In America Harrow + Wunderink + Open Dialogue = An Evidence-based Mandate for A New Standard of Care - Mad In America](https://www.madinamerica.com/custom_template/author_photos/Maria%20Mangicaro.jpg)
Harrow + Wunderink + Open Dialogue = An Evidence-based Mandate for A New Standard of Care - Mad In America
![Physical activity monitoring to assess disability progression in multiple sclerosis - Charlotte M Stuart, Aravinthan Varatharaj, Janine Domjan, Sheaba Philip, Ian Galea, , SIMS study group, SIMS study group, 2020 Physical activity monitoring to assess disability progression in multiple sclerosis - Charlotte M Stuart, Aravinthan Varatharaj, Janine Domjan, Sheaba Philip, Ian Galea, , SIMS study group, SIMS study group, 2020](https://journals.sagepub.com/cms/10.1177/2055217320975185/asset/images/large/10.1177_2055217320975185-fig2.jpeg)
Physical activity monitoring to assess disability progression in multiple sclerosis - Charlotte M Stuart, Aravinthan Varatharaj, Janine Domjan, Sheaba Philip, Ian Galea, , SIMS study group, SIMS study group, 2020
![Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece | SpringerLink Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40120-022-00384-2/MediaObjects/40120_2022_384_Fig1_HTML.png)
Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece | SpringerLink
![IJMS | Free Full-Text | Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis IJMS | Free Full-Text | Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis](https://pub.mdpi-res.com/ijms/ijms-21-09067/article_deploy/html/images/ijms-21-09067-g001.png?1606795090)